Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-20-021009
Date:2020-07-31
Issuer: SOLENO THERAPEUTICS INC (SLNO)
Original Submission Date:

Reporting Person:

COLLINSON STUART J
203 REDWOOD SHORES PKWY, STE 500
REDWOOD CITY, CA 94065

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-07-31 A 1,018 a $1.72 1,018 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the reported securities are represented by restricted stock units ("rsus"). each rsu represents a contingent right to receive one share of slno common stock. the rsus fully vest on july 31, 2020. the rsus are for the benefit of, and ultimately will be transferred to, forward ventures v, l.p. of which the reporting person serves as a managing member.
WhaleWisdom Logo

Elevate your investments